The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
Abstract
Class I major histocompatibility complex (MHC) molecules present antigens that are produced within the presenting cell or penetrate from the vacuolar system into the cytosol for processing. Most studies of exogenous antigen processing have used soluble antigens, which are not efficiently presented by class I MHC molecules and do not elicit CD8 T-cell responses in vivo. But particulate antigen preparations with no known mechanism for cytosolic penetration can also elicit CD8 T-cell responses in vivo. We report here that phagocytosis of bacteria with no mechanism for cytosolic penetration also results in presentation of bacterial antigens by class I MHC molecules. Moreover, this mechanism is resistant to cycloheximide and Brefeldin A, which block the classical class I processing pathway. These results suggest a novel vacuolar class I processing pathway for exogenous phagocytic antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We demonstrate that bacterial HLA-I and HLA-II peptides can be presented by both antigen-presenting cells (as has previously been shown25–28) and by melanoma cells”
From Identification of bacteria-derived HLA-bound peptides in melanoma (2021) · cites this paper as [26]
Citations
Cites
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,421
Bevan, M. J. (1976) · The Journal of Experimental Medicine · doi:10.1084/jem.143.5.1283 · Cited by 984
Fibronectin binding mediated by a novel class of surface organelles on Escherichia coll
Olsén, A., Jonsson, A., & Normark, S. J. (1989) · Nature · doi:10.1038/338652a0 · Cited by 614
Self-citationSequence of chicken ovalbumin mRNA
McReynolds, L. A., O’Malley, B. W., Nisbet, A. D., Fothergill, J. E., Givol, D., Fields, S., Robertson, M., & Brownlee, G. G. (1978) · Nature · doi:10.1038/273723a0 · Cited by 435
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
Carbone, F., & Bevan, M. J. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.2.377 · Cited by 400
Promoters largely determine the efficiency of repressor action.
Lanzer, M., & Bujard, H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8973 · Cited by 362
Presentation of Exogenous Antigen with Class I Major Histocompatibility Complex Molecules
Rock, K. L., Gamble, S., & Rothstein, L. (1990) · Science · doi:10.1126/science.2392683 · Cited by 335
Antigen Presentation Pathways to Class I and Class II MHC‐Restricted T Lymphocytes
Braciale, T. J., Morrison, L. A., Sweetser, M. T., Sambrook, J., Gething, M.-J. H., & Braciale, V. L. (1987) · Immunological Reviews · doi:10.1111/j.1600-065x.1987.tb00521.x · Cited by 320
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization.
Carbone, F., & Bevan, M. J. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.3.603 · Cited by 220
Sarmiento, M., Dialynas, D. P., Lancki, D. W., Wall, K. A., Lorber, M. I., Loken, M. R., & Fitch, F. W. (1982) · Immunological Reviews · doi:10.1111/j.1600-065x.1982.tb01063.x · Cited by 210
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 611
Darji, A., Chakraborty, T., Wehland, J., & Weiß, S. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270609 · Cited by 38
Gray, R. C., Kuchtey, J., & Harding, C. V. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006606 · Cited by 37
“3 T hybridoma cells, which detect OVA257–264:K b complexes [26].”
BackgroundSelf-citationInvolvement of an ATP-Dependent Peptide Chaperone in Cross-Presentation After DNA Immunization
Kumaraguru, U., Rouse, R. J. D., Nair, S. K., Bruce, B. D., & Rouse, B. T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.750 · Cited by 37
“Candidate mechanisms include the cell to cell transfer of MHC-binding peptides perhaps regurgitated from phagocytic cells (15) or alternatively molecular chaperones, such as hsp70 or gp96, may bind the peptides and mediate their transfer between cells (14).”
BackgroundCytotoxic T Lymphocytes in Resistance to Tuberculosis
Mazzaccaro, R. J., Stenger, S., Rock, K. L., Porcelli, S. A., Brenner, M. B., Modlin, R. L., & Bloom, B. R. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5355-7_11 · Cited by 37
Rojas, R. E., Torres, M., Fournié, J., Harding, C. V., & Boom, W. H. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.4019-4027.2002 · Cited by 37
“BFA blocks the supply of nascent MHC-I and MHC-II molecules to the endogenous and endocytic pathways, respectively, and inhibits the formation of most peptideMHC complexes in the endoplasmic reticulum or in late endocytic compartment (2, 38).”
BackgroundSelf-citationStimulation of protective CD8+ T lymphocytes by vaccination with nonliving bacteria.
Szalay, G., Ladel, C. H., & Kaufmann, S. H. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12389 · Cited by 37
Jensen, E. R., Shen, H., Wettstein, F. O., Ahmed, R., & Miller, J. F. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01001.x · Cited by 37
Presentation of an exogenous antigen by major histocompatibility complex class I molecules
Ulmer, J. B., Donnelly, J., & Liu, M. A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240721 · Cited by 37
Lee, Y.-R., Lee, Y., Im, S., Yang, I. H., Ahn, G. W., Kim, K., & Lee, C. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1119-z · Cited by 37
“DOBW and CD8 OVA T cells were provided by Dr. Clifford V. Harding (Case Western Reserve University) (Harding et al., 1991; Pfeifer et al., 1993).”
MethodDendritic Cell Cross-Priming Is Essential for Immune Responses to Listeria monocytogenes
Reinicke, A. T., Omilusik, K. D., Basha, G., & Jefferies, W. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007210 · Cited by 36
“Cross-presentation of bacterial antigens on MHC I has been demonstrated in vitro [17] and several groups have provided data for a mechanism whereby apoptosis of infected cells would provide the source of antigen and result in uptake of bacteria-encoded”
BackgroundAskew, D. S., & Harding, C. V. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02711.x · Cited by 36
Self-citationImmunosuppression of thyroiditis.
Guimarães, V. C., Quintáns, J., Fisfalen, M. E., Straus, F. H., Fields, P. E., Medeiros-Neto, G. A., & DeGroot, L. J. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641166 · Cited by 36
Breakdown of CTL Tolerance to Self HLA-B*2705 Induced by Exposure to Chlamydia trachomatis
Popov, I., Cruz, C. S. D., Barber, B. H., Chiu, B., & Inman, R. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.4033 · Cited by 36
“It is known that Ag derived from intracellular bacteria may lead to activation of CD8 lymphocytes via class I-mediated pathways (7), thereby invoking CD8 CTL in a central role in resistance to these bacteria (8).”
BackgroundLagoo, A. S., Eldridge, J. H., Lagoo‐Deenadaylan, S., Black, C. A., Ridwan, B. U., Hardy, K. J., McGhee, J. R., & Beagley, K. W. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241226 · Cited by 36
Vaccine Efficacy of Fusogenic Liposomes Containing Tumor Cell-Lysate against Murine B16BL6 Melanoma
Yoshikawa, T., Okada, N., Tsujino, M., Gao, J., Hayashi, A., Tsutsumi, Y. M., Mayumi, T., Yamamoto, A., & Nakagawa, S. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.100 · Cited by 35
Mukai, Y., Yoshinaga, T., Yoshikawa, M., Matsuo, K., Yoshikawa, T., Matsuo, K., Niki, K., Yoshioka, Y., Okada, N., & Nakagawa, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001093 · Cited by 35
“3 cells, a T–T hybridoma against OVA257–264/H-2K b complex (15, 16), were kindly provided by Dr.”
MethodQimron, U., Kela-Madar, N., Mittrücker, H., Zilka, A., Yosef, I., Bloushtain, N., Kaufmann, S. H. E., Rosenshine, I., Apte, R. N., & Porgador, A. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00418.x · Cited by 36
“© 2004 Blackwell Publishing Ltd, Cellular Microbiology, 6, 1057–1070 from the pQE-OVA8, we tested the well-studied pJLP-2H plasmid encoding the fusion protein Crl-OVA, which contains residues 257–277 of OVA including the OVA8 epitope (Pfeifer et al., 1993).”
MethodAntigen presentation in vaccine development
Takahashi, H. (2003) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/s0147-9571(03)00017-1 · Cited by 36
Umemura, M., Nishimura, H., Saito, K., Yajima, T., Matsuzaki, G., Mizuno, S., Sugawara, I., & Yoshikai, Y. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.6045-6048.2003 · Cited by 35
“Although exogenous particulate Ags such as PPD are usually present in association with MHC class II, Ags in the extracellular milieu can also be processed and presented in association with MHC class I (10), which is usually required for activation of CD8 T cells.”
Chaperot, L., Chokri, M. A., Jacob, M.-C., Drillat, P., Garban, F., Egelhofer, H., Molens, J.-P., Sotto, J., Bensa, J.-C., & Plumas, J. (2000) · Leukemia · doi:10.1038/sj.leu.2401888 · Cited by 35
Leão, S. C., Rocha, C. L., Murillo, L. A., Parra, C. A., & Patarroyo, M. E. (1995) · Infection and Immunity · doi:10.1128/iai.63.11.4301-4306.1995 · Cited by 35
“Although an alternative pathway for the presentation of class I-restricted antigens has been recently suggested to explain the antigen processing of pathogens that live inside the vacuole (27), the explanation for presentation of class I-restricted antigens in tuberculosis could be that the bacilli escape from the vac…”
BackgroundPhagocyte‐induced antigen‐specific activation of unprimed CD8+ T cells in vitro
Bruijn, M. L. H. D., Jackson, M. R., & Peterson, P. A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250522 · Cited by 35
Nataraj, C., Brown, M. L., Poston, R. M., Shawar, S. M., Rich, R. R., Lindahl, K. F., & Kurlander, R. J. (1996) · International Immunology · doi:10.1093/intimm/8.3.367 · Cited by 35
The evolving biology of cross-presentation
Ohara, R. A., & MURPHY, K. M. M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101711 · Cited by 37
MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells
Silva, Z., Ferro, T., Almeida, D. S., Soares, H., Ferreira, J. A., Deschepper, F. M., Hensbergen, P. J., Pirro, M., van Vliet, S. J., Springer, S., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030249 · Cited by 34
Dijkstra, J. M., Fischer, U., Sawamoto, Y., Ototake, M., & Nakanishi, T. (2001) · Fish & Shellfish Immunology · doi:10.1006/fsim.2001.0351 · Cited by 34
Polyomavirus-Infected Dendritic Cells Induce Antiviral CD8+T Lymphocytes
Drake, D. R., Moser, J. M., Hadley, A., Altman, J. D., Maliszewski, C. R., Butz, E. A., & Lukacher, A. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4093-4101.2000 · Cited by 34
“Several studies also suggest that Mf are as efficient as DC in inducing primary CD8(1) T-cell responses (19, 59), while others suggest that DC and Mf may interact to generate CTL-mediated immune responses (20, 46).”
BackgroundSvane, I. M., Boesen, M., & ENGEL, A. ‐. (1999) · Medical Oncology · doi:10.1007/bf02785868 · Cited by 34
STOROZYNSKY, WOODWARD, Frelinger, & LORD (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00741.x · Cited by 34
Advances in the development of bacterial vector technology
Kochi, S. K., Killeen, K., & Ryan, U. S. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.1.31 · Cited by 34
Cross-Presentation of Cell-Associated Antigens by Dendritic Cells
Larsson, M., Fonteneau, J., & Bhardwaj, N. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-06508-2_12 · Cited by 34
Patterson, B. K., Goolsby, C., Hodara, V. L., Lohman, K. L., & Wolinsky, S. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4316-4322.1995 · Cited by 34
Zügel, U., & Kaufmann, S. H. E. (1997) · Infection and Immunity · doi:10.1128/iai.65.9.3947-3950.1997 · Cited by 34
“These studies favor an alternative pathway capable of translocating antigens from pathogenic microbes which stay in the endosome (14).”
BackgroundThe GTPase Rab39a promotes phagosome maturation into MHC‐I antigen‐presenting compartments
Cruz, F. M., Colbert, J. D., & Rock, K. L. (2019) · The EMBO Journal · doi:10.15252/embj.2019102020 · Cited by 33
“Antigens internalized by phagocytosis are cross-presented 10 3 – 10 4 -fold more efficiently than ones acquired by fluid-phase endocytosis (Kovacsovics-Bankowski et al , 1993; Pfeifer et al , 1993; Hard-ing & Song, 1994).”
Wu, Y., Wan, Y., Bian, J., Zhao, J., Jia, Z., Zhou, L., Zhou, W., & Tan, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10260 · Cited by 33
Schultz, H., Schinke, S., Weiss, J. P., Cerundolo, V., Gross, W. L., & Gadola, S. D. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02197.x · Cited by 32
Infection-Induced Expansion of a MHC Class Ib-Dependent Intestinal Intraepithelial γδ T Cell Subset
Davies, A., López-Briones, S., Ong, H., O’Neil-Marshall, C., Lemonnier, F. A., Nagaraju, K., Metcalf, E. S., & Soloski, M. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6828 · Cited by 32
Cellular immunity to intracellular bacteria
Pamer, E. G. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90028-q · Cited by 32
Zhu, X. W. (1997) · International Immunology · doi:10.1093/intimm/9.11.1669 · Cited by 32
Wick, M. J., Pfeifer, J. D., Findlay, K. A., Harding, C. V., & Normark, S. J. (1993) · Infection and Immunity · doi:10.1128/iai.61.11.4848-4856.1993 · Cited by 32
“This is a likely result on the basis of the high copy number of the pUC18 vector of the Crl fusion proteins and the constitutive expression from the native crl promoter (42, 43).”
BackgroundMethodInfluentialSelf-citationBacterial infection and microbiota in carcinogenesis and tumor development
Li, Q. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1294082 · Cited by 32
Intracellular events regulating cross-presentation
Wagner, C., Grotzke, J. E., & Cresswell, P. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00138 · Cited by 35
Induction of Specific Immune Responses by Polycation-Based Vaccines
Lührs, P., SCHMIDT, W. A., Kutil, R., Buschle, M., Wagner, S. N., Stingl, G., & Schneeberger, A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5217 · Cited by 31
Lee, Y.-R., Lee, Y., Kim, K., Im, S., & Lee, C. (2013) · Immune Network · doi:10.4110/in.2013.13.1.30 · Cited by 31
Balaji, K. N., & Boom, W. H. (1998) · Infection and Immunity · doi:10.1128/iai.66.1.98-106.1998 · Cited by 31
“For inhibition of ongoing antigen processing, monocytes were preincubated for 8 to 12 h with the antigens indicated in the figures before addition of chloroquine (400 mM) or Brefeldin A (5 mg/ml) according to published procedures (3, 14, 30).”
MethodCheadle, E. J., O’Donnell, D., Selby, P. J., & Jackson, A. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.784-794.2005 · Cited by 31
“coli and Salmonella enterica serovar Typhimurium, is presented on cell surface MHC class I in macrophages (41), dendritic cells (45, 50) and neutrophils (44).”
BackgroundMartín‐Orozco, N., Isibasi, A., & Ortiz-Navarrete, V. F. (2001) · Immunology · doi:10.1046/j.0019-2805.2001.01226.x · Cited by 31
Wassenaar, A., Reinhardus, C., Abraham-Inpijn, L., & Kievits, F. (1996) · PubMed Central · Cited by 31
Cruz‐Leal, Y., Grubaugh, D., Nogueira, C. V., Lopetegui-Gonzalez, I., del Valle, A., Escalona, F., Laborde, R. J., Álvarez, C., Fernandez, L. E., Starnbach, M. N., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02473 · Cited by 30
“These observations are consistent with the phagocytic antigen processing pathway for presenting bacterial antigens in MHC class I molecules (43).”
ResultEhser, S., Chuang, J. J., Kleist, C., Șandra-Petrescu, F., Iancu, M., Wang, D., Opelz, G., & Terness, P. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.01.018 · Cited by 30
Immunology of psoriasis and psoriatic arthritis
Panayi, G. S. (1994) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(94)80026-x · Cited by 30
Fonseca, D. P. A. J., Joosten, D., van der Zee, R., Jue, D. L., Singh, M., Vordermeier, H. M., Snippe, H., & Verheul, A. F. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.7.3190-3197.1998 · Cited by 30
“, phagosomes or phagolysosomes) or on the cell surface following peptide regurgitation (21, 29).”
BackgroundHansen, T. H., Balendiran, G. K., Solheim, J. C., Ostrov, D. A., & Nathenson, S. G. (2000) · Immunology Today · doi:10.1016/s0167-5699(98)01426-1 · Cited by 30
Partially TAP-Independent Protection Against Listeria monocytogenes by H2-M3-Restricted CD8+ T Cells
Rolph, M. S., & Kaufmann, S. H. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4575 · Cited by 30
“(29) for MHC class Ia, is not likely as bystander cells are not loaded with peptide when cultured together with HKLpulsed macrophages (30).”
BackgroundKim, C., Matsumura, M., Saijo, K., & Ohno, T. (1998) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050508 · Cited by 29
“It has been shown that phagocytic processing of exogenous antigens occurs in macrophages in which the processed antigenic peptides bind to MHC class I molecules [ 19 ].”
BackgroundZhao, C., Wood, M. W., Galyov, E. E., Höpken, U. E., Lipp, M., Bodmer, H. C., Tough, D. F., & Carter, R. W. (2006) · European Journal of Immunology · doi:10.1002/eji.200636179 · Cited by 29
Selective release of peptides from lysosomes.
Isenman, L. D., & Dice, J. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80464-5 · Cited by 29
Garcia, M. R., Graham, S., Harris, R. A., Beverley, S. M., & Kaye, P. M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270430 · Cited by 29
Lapham, C. K., Golding, B., Inman, J. K., Blackburn, R. J., Manischewitz, J. F., Highet, P. F., & Golding, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3084-3092.1996 · Cited by 29
“macrophages will process external particulate antigens (bacterial antigens, viruses, or proteins bound to silica beads) for presentation by preexisting MHC class I molecules (12, 13, 16, 27).”
BackgroundCourse of Leishmania infection in β2-microglobulin-deficient mice
Overath, P., & Harbecke, D. (1993) · Immunology Letters · doi:10.1016/0165-2478(93)90126-m · Cited by 28
Kuon, W., Lauster, R., Böttcher, U., Koroknay, A., Ulbrecht, M., Hartmann, M., Grolms, M., Ugrinović, S., Braun, J., Weiss, E. H., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400524 · Cited by 28
Wan, Y., Wu, Y., Zhou, J., Zou, L., Liang, Y., Zhao, J., Jia, Z., Engberg, J., Bian, J., & Zhou, W. (2005) · European Journal of Immunology · doi:10.1002/eji.200425322 · Cited by 27
Hone, D. M., Wu, S., Powell, R. J., Pascual, D. W., Cott, J. V., McGhee, J. R., FOUTS, T. R., Tuskan, R. G., & Lewis, G. K. (1996) · Journal of Biotechnology · doi:10.1016/0168-1656(95)00151-4 · Cited by 27
Heat shock proteins and the antitumor T cell response
Harada, M., Kimura, G., & Nomoto, K. (1998) · Biotherapy · doi:10.1007/bf02678301 · Cited by 27
“In addition, there have also been an increasing number of reports indicating that macrophages have the potential to present exogenous antigens in association with MHC class I molecules [ 24 - 26 ].”
BackgroundInduction of Lyt-2+ cytotoxic T lymphocytes following primary and secondary Salmonella infection.
Pope, M., Kotlarski, I., & Doherty, K. (1994) · PubMed Central · Cited by 27
Harding, C. V., & Pfeifer, J. D. (1994) · PubMed Central · Cited by 27
Self-citationHayashi, A., Wakita, H., Yoshikawa, T., Nakanishi, T., Tsutsumi, Y. M., Mayumi, T., Mukai, Y., Yoshioka, Y., Okada, N., & Nakagawa, S. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.011 · Cited by 26
Cardinal, J. W., Allan, D. J., & Cameron, D. P. (1998) · Endocrinology · doi:10.1210/endo.139.6.6048 · Cited by 26
Lo‐Man, R., Langeveld, J., Dériaud, E., Jéhanno, M., Rojas, M., Clément, J.-M., Meloen, R. H., Hofnung, M. J., & Leclerc, C. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3079-3089.2000 · Cited by 26
“However, in vitro, Salmonella can deliver Ag in either the MHC class I or class II pathway of Mf and DC (38, 53).”
BackgroundSong, Porgador, A., & Harding (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00759.x · Cited by 26
H2‐M3 Restricted Presentation of Listeria monocytogenes Antigens
Lenz, L. L., & Bevan, M. J. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00705.x · Cited by 26
Salmonella Modulates B Cell Biology to Evade CD8+ T Cell-Mediated Immune Responses
López‐Medina, M., Pérez-López, A., Alpuche-Aranda, C. M., & Ortiz-Navarrete, V. F. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00586 · Cited by 25
“MHC-I molecules (17); (3) the antigen is cross-processed through a phagosome-cytosol-phagosome alternating pathway (18); and (4) peptides are processed in a previously non-characterized endocytic compartment, secreted into the cytosol, and loaded onto empty MHC-I molecules on the surfaces of macrophages and bystander…”
BackgroundOlazabal, I. M., Martin-Cofreces, N. B., Mittelbrunn, M., del Hoyo, G. M., Alarcón, B., & Sánchez‐Madrid, F. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-07-0650 · Cited by 25
“…studied for their ability to cross-present antigens from phagocytosed pathogens through the major histocompatibility complex (MHC)-class I pathway (Pfeifer et al., 1993; Oliveira and Splitter, 1995; Reis e Sousa and Germain, 1995; Turner and Dockrell, 1996; Oh et al., 1997; Belkaid et al., 2002;…”
BackgroundOjcius, D. M., Hellio, R., & Dautry‐Varsat, A. (1997) · Infection and Immunity · doi:10.1128/iai.65.6.2437-2442.1997 · Cited by 25
“Along similar lines, a novel pathway linking phagosomes with the cytosol of antigenpresenting cells has recently been described (21, 28), and it is conceivable that Chlamydia could exploit this pathway.”
BackgroundIn Vitro Human Memory CD8 T Cell Expansion in Response to Cytomegalovirus Requires CD4+T Cell Help
Salkowitz, J. R., Sieg, S. F., Harding, C. V., & Lederman, M. M. (2004) · The Journal of Infectious Diseases · doi:10.1086/382032 · Cited by 24
Self-citationDNA Vaccines and Immunity to Herpes Simplex Virus
Rouse, B. T., Nair, S. K., Rouse, R. J. D., Yu, Z., Kuklin, N. A., Karem, K. L., & Manickan, E. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80475-5_5 · Cited by 25
Neutrophils: Neglected Players in Viral Diseases
Gabriel, C., Her, Z., & Ng, L. F. P. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.2211 · Cited by 23
“…derived from a common hematopoietic cell progenitor (Inaba et al. , 1993) and share several common features in phagocytosis, antigen presentation (Pfeifer et al. , 1993; Berg et al. , 1994; Kovacsovics-Bankowski and Rock, 1995; Beauvillain et al. , 2007; Abi Abdallah et al. , 2011; Ostanin et…”
Reduced CD8+ peripheral blood T lymphocytes in rapidly progressive periodontitis
Nagasawa, T., Nitta, H., Watanabe, H., & Ishikawa, I. (1995) · Archives of Oral Biology · doi:10.1016/0003-9969(95)00025-k · Cited by 24
Janda, J., Schöneberger, P., Škoberne, M., Messerle, M., Rüssmann, H., & Geginat, G. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5644 · Cited by 24
“The strict requirement for proteasome-mediated Ag processing by DC also ruled out peptide regurgitation (5), a scenario that is also highly unlikely, because in our system the Ag donor cell and the APC did not share MHC class I molecules.”
BackgroundDendritic Cell–Dead Cell Interactions: Implications and Relevance for Immunotherapy
Fonteneau, J., Larsson, M., & Bhardwaj, N. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200107000-00005 · Cited by 24
“After the original description of cross-presentation of minor histocompatibility antigens by Bevan (2), the phenomenon that CTLs could be activated through exogenous pathways was extended to other antigens, including self-antigens (20), viruses (11, 21,22), bacteria (14,23), parasites (24), and tumor antigens (25).”
BackgroundWang, H., Yu, X., Guo, C., Zuo, D., Fisher, P. B., Subjeck, J. R., & Wang, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302312 · Cited by 23
Choosing and Preparing Antigen‐Presenting Cells
Harding, C. V., Canaday, D. H., & Ramachandra, L. (2010) · Current Protocols in Immunology · doi:10.1002/0471142735.im1601s88 · Cited by 23
Self-citationJohansson, C., Nilsson, T., Olsén, A., & Wick, M. J. (2001) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(00)00228-5 · Cited by 23
Self-citationPATHOGENESIS OF HUMAN LEUKOCYTE ANTIGEN B27–POSITIVE ARTHRITIS
Märker‐Hermann, E., & Höhler, T. (1998) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70046-6 · Cited by 23
Cao, H., Agrawal, D., Kushner, N. N., Touzjian, N., Essex, M., & Lu, Y. (2002) · The Journal of Infectious Diseases · doi:10.1086/338448 · Cited by 23
“The presentation of many exogenous antigens on MHC-I molecules involves proteolysis in the endocytic compartment [36–38], and the peptides subsequently gain access to the cytosol where they enter the MHC class I pathway.”
BackgroundIdentification of HLA-B27–restricted peptides in reactive arthritis and other spondyloarthropathies
Kuon, W., & Sieper, J. (2003) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(03)00050-4 · Cited by 23
Brander, C., Wyss‐Coray, T., Mauri, D. N., Bettens, F., & Pichler, W. J. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231226 · Cited by 23
Spontaneous transgenesis of human B lymphocytes
Filaci, G., Gerloni, M., Rizzi, M., Castiglioni, P., Chang, H.-D., Wheeler, M., Fiocca, R., & Zanetti, M. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302132 · Cited by 23
Martin, S. F., Niedermann, G., Leipner, C., Eichmann, K., & Weltzien, H. U. (1993) · Immunology Letters · doi:10.1016/0165-2478(93)90017-v · Cited by 23
Zwickey, H. L., & Potter, T. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6341 · Cited by 23
Hess, J., Grode, L., Gentschev, I., Fensterle, J., Dietrich, G., Goebel, W., & Kaufmann, S. H. E. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01333-2 · Cited by 23
Intracellular Transport of Molecules Engaged in the Presentation of Exogenous Antigens
Nordeng, T. W., Gorvel, J., & Bakke, O. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-72045-1_9 · Cited by 22
FULLER, D. H., Shipley, T., Allen, T. M., Fuller, J. T., Wu, M. S., Horton, H., Wilson, N. A., Widera, G., & Watkins, D. I. (2007) · Virology · doi:10.1016/j.virol.2007.02.024 · Cited by 22
“Phagocytic macrophages can process particulate antigens via the exogenous class I pathway (Kovacsovics-Bankowski et al., 1993; Pfeifer et al., 1993), and particulate protein-based vaccines induce CD8+ T cell responses via this mechanism (Griffiths et al., 1993; Layton et al., 1993; Schirmbeck et…”
BackgroundPeptides Bound to Major Histocompatibility Complex Molecules
Maffei, A., & Harris, P. E. (1998) · Peptides · doi:10.1016/s0196-9781(97)00277-5 · Cited by 22
Bacterial modulation of antigen processing and presentation
Maksymowych, W. P., & Kane, K. P. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00268-9 · Cited by 22
Modulation of T cell function and survival by the tumor microenvironment
Mani, N. L., Andrews, D., & Obeng, R. C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1191774 · Cited by 22
“Although macrophages (Pfeifer et al., 1993; Rock et al., 1993), neutrophils (Tvinnereim et al.”
Progress in the Development of Multivalent Oral Vaccines Based on Live Attenuated Salmonella
Chatfield, S. N., Gordon Dougan, B., & Roberts, M. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1450-7_5 · Cited by 21
Zhou, X., Liu, T., Franksson, L., Lederer, E., Ljunggren, H., & Jondal, M. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03627.x · Cited by 21
Bacterial Systems for the Delivery of Eukaryotic Antigen Expression Vectors
DIETRICH, G., Spreng, S., Gentschev, I., & Goebel, W. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.391 · Cited by 21
“Nevertheless, infection of primary macrophages with S. typhimurium results in the presentation of phagosomal proteins together with MHC class I molecules (Pfeifer et al., 1993).”
Metadata
- Authors
- Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., & Harding, C. V.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Nature
- Published
- 1993-01
- Volume
- 361
- Issue
- 6410
- Pages
- 359-362
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2042470561
- Cited by
- 615
- References
- 31
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 6 · 2018: 8 · 2017: 9 · 2015: 4 · 2014: 8 · 2013: 10 · 2012: 10
- FWCI
- 22.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- MHC class I, antigen processing, phagocytosis, bacterial antigens, CD8+ T cells, exogenous antigen presentation, cycloheximide resistance, particulate antigen
- MeSH terms
- Amino Acid Sequence, Animals, Epitopes, Antigens, Bacterial, Bacterial Proteins, Escherichia coli, Macrophages, Mice, Inbred CBA, Mice, Inbred C57BL, Microscopy, Electron, Molecular Sequence Data, Ovalbumin, Phagocytosis, Recombinant Fusion Proteins, Salmonella typhimurium, T-Lymphocytes, Vacuoles, Histocompatibility Antigens Class I, T-Lymphocyte Subsets, CD8 Antigens, Escherichia coli Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review